BioBusiness - Novozymes

More documents

Recommendations

Info

6 8/9/2009 NOVOZYMES' CAPITAL MARKETS DAY The road to becoming a DKK multibillion business 5-10 years • Existing business •BPI • Acquisitions 10+ years • Existing business • Renewable chemicals • Acquisitions 0-5 years • Existing business • BioAg •HA • Acquisitions
7 8/9/2009 NOVOZYMES' CAPITAL MARKETS DAY <strong>BioBusiness</strong>’ B i business areas Microorganisms Biopharmaceutical Ingredients (BPI) Business building activities Microorganisms for industrial & agricultural applications Biopharmaceutical products & technologies and biopolymers Acquisition, integration work & business development Leveraging <strong>Novozymes</strong>’ core capabilities of: • Molecular biology, bioinformatics, and system biology • Screening • Industrial-scale fermentation • Delivering technology to market
Page 1 and 2: BioBusiness Strategy & activities T
Page 3 and 4: 3 8/9/2009 NOVOZYMES' CAPITAL MARKE
Page 5: 5 8/9/2009 NOVOZYMES' CAPITAL MARKE
Page 9 and 10: 9 8/9/2009 NOVOZYMES' CAPITAL MARKE
Page 11 and 12: 11 8/9/2009 NOVOZYMES' CAPITAL MARK
Page 17 and 18: BioBusiness Novozymes’ solutions
Page 21 and 22: 21 09/09/2009 NOVOZYMES' CAPITAL MA

BioBusiness - Novozymes

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?